Altimmune, Inc. (ALT) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Altimmune, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.756 Good morning, ladies and gentlemen, and welcome to the Altamune First Quarter 2025 Financial 00:00:05.756 -- 00:00:10.840 Results Conference Call. After the speaker's presentation, there will be a question and 00:00:10.840 -- 00:00:15.865 answer session. To ask a question during the session, you will need to press star 11 00:00:15.865 -- 00:00:21.770 on your telephone. You will then hear an automated message advising your hand is raised. 00:00:21.770 -- 00:00:26.134 To withdraw your question, please press star 11 again. 00:00:26.134 -- 00:00:30.068 As a reminder, this call is being recorded. 00:00:30.068 -- 00:00:35.095 I'll now introduce your host for today's conference call, Lee Roth, President 00:00:35.095 -- 00:00:39.160 of Burns McClellan, Investor Relations Advisor to Altamune. 00:00:39.160 -- 00:00:40.362 Lee, you may begin. 00:00:40.362 -- 00:00:42.264 Thanks, 00:00:42.264 -- 00:00:46.870 Gigi, and good morning, everyone. Once again, thank you all for joining us for Altamune's 00:00:46.870 -- 00:00:51.817 first quarter 2025 Financial Results and Business Update conference call. 00:00:51.817 -- 00:00:56.163 On today's call, you'll hear from Dr. Vipengar, our Chief Executive Officer, Dr. 00:00:56.163 -- 00:01:00.832 Scott Harris, our Chief Medical Officer, and Greg Weaver, our Chief Financial Officer. 00:01:00.832 -- 00:01:05.658 Dr. Scott Roberts, our chief scientific officer, and Ray George, our chief business officer, 00:01:05.658 -- 00:01:08.402 are with us for the Q&A session. 00:01:08.402 -- 00:01:12.467 Our first quarter 2025 results and corporate update press release was issued earlier 00:01:12.467 -- 00:01:17.354 this morning and can be found on the investor relations section of the Altimmune website. 00:01:17.354 --...